Clinical Trials Directory

Trials / Unknown

UnknownNCT05471687

Evaluation of the Functional Impact of Coronary Stenoses in Diabetics by Spectral CT

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The optimal screening methods for coronary insufficiency, a frequent and pejorative complication in diabetics, are subject to debate, particularly in situations of silent myocardial ischemia. The contemporary strategy consists of pre-selecting asymptomatic patients at very high cardiovascular (CV) risk by performing a coronary calcium score. If this is found to be high \>300 AU (Agatston units), the patient is suspected of being at high risk of silent myocardial ischemia (SMI), and the assessment is completed to exclude the presence of coronary artery disease likely to benefit from revascularization. The complementary evaluation consists in evaluating the myocardial perfusion to judge the perfusion repercussions. The most common examination to date is myocardial scintigraphy, because stress tests are too frequently submaximal in diabetics. However, the reproducibility of scintigraphy is controversial and their sensitivity and specificity are debated in this indication. This problem is similar in stable symptomatic coronary diabetic patients for whom an indication for functional examinations is justified. The double-energy double-layer spectral scanner (SDEDC) could now become a relevant tool in this field, since it can combine not only anatomical data (identification of coronary stenosis) but also functional data (myocardial perfusion) during a stress protocol. thanks to the spectral images which make it possible to measure the tissue concentration of intramyocardial iodine downstream of the considered stenosis.

Conditions

Interventions

TypeNameDescription
DEVICEdual-energy dual-layer spectral scannerRealization of dual-energy dual-layer spectral scanner with stress protocol
DRUGStress protocol with adenosin during dual-energy dual-layer spectral scannerInjection of intraveinous adenosin dose 0.78 mg/kg during dual-energy dual-layer spectral scanner

Timeline

Start date
2022-09-01
Primary completion
2024-09-01
Completion
2025-03-01
First posted
2022-07-25
Last updated
2022-07-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05471687. Inclusion in this directory is not an endorsement.